Influence of pH gradients on the transbilayer transport of drugs, lipids, peptides and metal ions into large unilamellar vesicles

Biochimica et Biophysica Acta - Reviews on Biomembranes

Volumn 1331, Issue 2, 1997, Pages 187-211

  Cullis, Pieter R ^a,b   Hope, Michael J ^b   Bally, Marcel B ^c   Madden, Thomas D ^a,b   Mayer, Lawrence D ^c   Fenske, David B ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b Inex Pharmaceuticals Corporation   (Canada)

^c BRITISH COLUMBIA CANCER AGENCY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; BIOGENIC AMINE; CHLOROQUINE; CHLORPROMAZINE; CINCHOCAINE; CODEINE; DAUNORUBICIN; DIPHENHYDRAMINE; DOPAMINE; DOXORUBICIN; EPIRUBICIN; IMIPRAMINE; IONOPHORE; LIDOCAINE; LIPID; MEPACRINE; MITOXANTRONE; PEPTIDE; PHOSPHOLIPID; PROPRANOLOL; QUINIDINE; QUININE; SEROTONIN; TIMOLOL; VINBLASTINE; VINCRISTINE;

IN VITRO STUDY; INTRACELLULAR TRANSPORT; MEMBRANE STRUCTURE; MEMBRANE TRANSPORT; MEMBRANE VESICLE; MODEL; PH; PRIORITY JOURNAL; REVIEW; THEORY;

ACIDS; ALKALIES; DRUG CARRIERS; DRUG COMPOUNDING; IONS; LIPIDS; LIPOSOMES; METALS; PEPTIDES; PHARMACEUTICAL PREPARATIONS; PROTON-MOTIVE FORCE;

CINCHONA PUBESCENS;

EID: 0030886615     PISSN: 03044157     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-4157(97)00006-3     Document Type: Review

References (123)

1. Jacobs M.H. Some aspects of cell permeability to weak electrolytes. Cold Spring Harbour Symp. Quant. Biol. 8:1940;30-39.
2. J.B. Chappel and A.R. Crofts, in: J.M. Tager, S. Papa, E. Quagliariello, E.C. Slater (Eds.), Regulation of Metabolic Processes in Mitochondria, Elsevier, Amsterdam, 1966, pp. 293-316.
3. Crofts A.R. Amine uncoupling of energy transfer in choroplasts. J. Biol. Chem. 242:1967;3352-3359.
4. A.R. Crofts, Ammonium ion uptake by choroplasts, and the high-energy state, in: J. Jarnefelt (Ed.), Regulatory Functions of Biological Membranes, Elsevier Publishing Co., Amsterdam, 1968, pp. 247-263.
5. Rottenberg H. The measurement of transmembrane electrochemical proton gradients. Bioenergetics. 7:1975;61-74.
6. Rottenberg H. The measurement of membrane potential and ΔpH in cells, organelles, and vesicles. Methods Enzymol. 55:1979;547-569.
7. Deamer D.W., Prince R.C., Crofts A.R. The response of fluorescent amines to pH gradients across liposome membranes. Biochim. Biophys. Acta. 274:1972;323-335.
8. Kornberg R.D., McNamee M.G., McConnell H.M. Measurement of transmembrane potentials in phospholipid vesicles. Proc. Natl. Acad. Sci. USA. 69:1972;1508-1513.
9. Cafiso D.S., Hubbell W.L. Estimation of transmembrane potentials from phase equilibria of hydrophobic paramagnetic ions. Biochemistry. 17:1978;187-195.
10. Cafiso D.S., Hubbell W.L. Estimation of transmembrane pH gradients from phase equilibria of spin-labelled amines. Biochemistry. 17:1978;3871-3877.
11. Nichols J.W., Deamer D.W. Catecholamine uptake and concentration by liposomes maintaining pH gradients. Biochim. Biophys. Acta. 455:1976;269-271.
12. Kraayenhorf R., Sterk G.J., Wong Fong Sang H.W. Probing biomembrane interfacial potential and pH profiles with a new type of float-like fluorophores positioned at varying distance from the membrane surface. Biochemistry. 32:1993;10057-10066.
13. McLaughlin S. Curr. Top. Membr. Transp. 9:1977;71-144.
14. Tocanne J.F., Teissie J. Ionization of phospholipids and phospholipid-supported interfacial lateral diffusion of protons in membrane model systems. Biochim. Biophys. Acta. 1031:1990;111-142.
15. Haran G., Cohen R., Bar L.K., Barenholz Y. Transmembrane ammonium sulfate gradients in liposomes produce efficient and stable entrapment of amphipathic weak bases. Biochim. Biophys. Acta. 1151:1993;201-215.
16. Ceh B., Lasic D.D. A rigorous theory of remote loading of drugs into liposomes. Langmuir. 11:1995;3356-3368.
17. Ceh B., Lasic D.D. A rigorous theory of remote loading of drugs into liposomes: transmembrane potential and induced pH-gradient loading and leakage of liposomes. J. Colloid Interface Sci. 185:1997;9-18.
18. Redelmeier T.E., Mayer L.D., Wong K.F., Bally M.B., Cullis P.R. Proton flux in large unilamellar vesicles in response to membrane potentials and pH gradients. Biophys. J. 56:1989;385-393.
19. Harrigan P.R., Hope M.J., Redelmeier T.E., Cullis P.R. Determination of transmembrane pH gradients and membrane potentials in liposomes. Biophys. J. 63:1992;1336-1345.
20. Minow R.A., Benjamin R.S., Lee E.T., Gottlieb J.A. Adriamycin cardiomyopathy - risk factors. Cancer. 39:1977;1397-1402.
21. Mayer L.D., Bally M.B., Cullis P.R. Uptake of adriamycin into large unilamellar vesicles in response to a pH gradient. Biochim. Biophys. Acta. 857:1986;123-126.
22. Mayer L.D., Tai L.C.L., Bally M.B., Mitilenes G.N., Ginsberg R.S., Cullis P.R. Characterization of liposomal systems containing doxorubicin entrapped in response to pH gradients. Biochim. Biophys. Acta. 1025:1990;143-151.
23. Mayer L.D., Tai L.C.L., Ko D.S.C., Masin D., Ginsberg R.S., Cullis P.R., Bally M.B. Influence of vesicle size, lipid composition, and drug-to-lipid ratio on the biological activity of liposomal doxorubicin in mice. Cancer Res. 49:1989;5922-5930.
24. Harrigan P.R., Wong K.F., Redelmeier T.E., Wheeler J.J., Cullis P.R. Accumulation of doxorubicin and other lipophilic amines Into large unilamellar vesicles in response to transmembrane pH gradients. Biochim. Biophys. Acta. 1149:1993;329-338.
25. Boman N.L., Mayer L.D., Cullis P.R. Optimization of the retention properties of vincristine in liposomal systems. Biochim. Biophys. Acta. 1152:1993;253-258.
26. Redelmeier T.E., Hope M.J., Cullis P.R. On the mechanism of transbilayer transport of phosphatidylglycerol in response to transmembrane pH gradients. Biochemistry. 29:1990;3046-3053.
27. Eastman S.J., Hope M.J., Cullis P.R. Transbilayer transport of phosphatidic acid in response to transmembrane pH gradients. Biochemistry. 30:1991;1740-1745.
28. Chakrabarti A.C., Clarke-Lewis I., Harrigan P.R., Cullis P.R. Uptake of basic amino acids and peptides into liposomes in response to transmembrane pH gradients. Biophys. J. 61:1992;228-234.
29. Chakrabarti A.C., Clark-Lewis I., Cullis P.R. Influence of charge, charge distribution, and hydrophobicity on the transport of short model peptides into liposomes in response to transmembrane pH gradients. Biochemistry. 33:1994;8479-8485.
30. Lasic D.D., Frederik P.M., Stuart M.C.A., Barenholz Y., McIntosh T.J. Gelation of liposome interior. A novel method for drug encapsulation. FEBS Lett. 312:1992;255-258.
31. Lasic D.D., Ceh B., Stuart M.C.A., Guo L., Frederik P.M., Barenholz Y. Transmembrane gradient driven phase transitions within vesicles: lessons for drug delivery. Biochim. Biophys. Acta. 1239:1995;145-156.
32. Mayer L.D., Bally M.B., Cullis P.R. Strategies for optimizing liposomal doxorubicin. J. Liposome Res. 1:1990;463-480.
33. Mayer L.D., Bally M.B., Cullis P.R., Wilson S.L., Emerman J.T. Comparison of free and liposome encapsulated doxorubicin tumor drug uptake and antitumor efficacy in the SC115 murine mammary tumor. Cancer Lett. 53:1990;183-190.
34. Bally M.B., Nayar R., Masin D., Cullis P.R., Mayer L.D. Studies on the myelosuppressive activity of doxorubicin entrapped in liposomes. Cancer Chemother. Pharmacol. 27:1990;13-19.
35. Bally M.B., Nayar R., Masin D., Hope M.J., Cullis P.R., Mayer L.D. Liposomes with entrapped doxorubicin exhibit extended blood residence times. Biochim. Biophys. Acta. 1023:1990;133-139.
36. Embree L., Gelmon K.A., Lohr A., Mayer L.D., Coldman A.J., Cullis P.R., Palaitis W., Pilkiewicz F., Hudon N.J., Heggie J.R., Goldie J.H. Chromatographic analysis and pharmacokinetics of liposome-encapsulated doxorubicin in non-small-cell lung cancer patients. J. Pharm. Sci. 82:1993;627-634.
37. Mayer L.D., Cullis P.R., Bally M.B. The use of transmembrane pH gradient-driven drug encapsulation in the pharmacodynamic evaluation of liposomal doxorubicin. J. Liposome Res. 4:1994;529-553.
38. Chonn A., Cullis P.R. Recent advances in liposomal drug delivery systems. Curr. Op. Biotechnol. 6:1995;698-708.
39. Harrison M., Tomlinson D., Stewart S. Liposomal-entrapped doxorubicin: an active agent in AIDS-related Kaposi's sarcoma. J. Clin. Oncol. 13:1995;914-920.
40. Mayer L.D., Bally M.B., Loughrey H., Masin D., Cullis P.R. Liposomal vincristine preparations which exhibit decreased drug toxicity and activity against murine L1210 and P388 tumors. Cancer Res. 50:1990;575-579.
41. Boman N.L., Masin D., Mayer L.D., Cullis P.R., Bally M.B. Liposomal vincristine which exhibits increased drug retention and increased circulation longevity cures mice bearing P388 tumors. Cancer Res. 54:1994;2830-2833.
42. Webb M.S., Harasym T.O., Masin D., Bally M.B., Mayer L.D. Sphingomyelin-cholesterol liposomes significantly enhance the pharmacokinetic and therapeutic properties of vincristine in murine and human tumor models. Br. J. Cancer. 72:1995;896-904.
43. Madden T.D., Harrigan P.R., Tai L.C., Bally M.B., Mayer L.D., Redelmeier T.E., Loughrey H.C., Tilcock C.P.S., Reinish L.W., Cullis P.R. The accumulation of drugs within large unilamellar vesicles exhibiting a proton gradient: a survey. Chem. Phys. Lipids. 53:1990;37-46.
44. Hope M.J., Cullis P.R. Lipid asymmetry induced by transmembrane pH gradients in large unilamellar vesicles. J. Biol. Chem. 262:1987;4360-4366.
45. Bailey A.L., Cullis P.R. Modulation of membrane fusion by asymmetric transbilayer distributions of amino lipids. Biochemistry. 33:1994;12573-12580.
46. Eastman S.J., Wilschut J., Cullis P.R., Hope M.J. Intervesicular exchange of lipids with weak acid and weak base characteristics: influence of transmembrane pH gradients. Biochim. Biophys. Acta. 981:1989;178-184.
47. Hope M.J., Redelmeier T.E., Wong K.F., Rodrigueza W., Cullis P.R. Phospholipid asymmetry in large unilamellar vesicles induced by transmembrane pH gradients. Biochemistry. 38:1989;4181-4187.
48. White J.M. Membrane fusion. Science. 258:1992;917-924.
49. P.R. Cullis, C.P. Tilcock, M.J. Hope, Lipid polymorphism, in: J. Wilschut, D. Hoekstra (Eds.) Membrane Fusion, Marcel Dekker, New York, 1990, pp. 35-64.
50. Siegel D.P. Energetics of intermediates in membrane fusion: comparison of stalk and inverted micellar intermediate mechanisms. Biophys. J. 65:1993;2124-2140.
51. 2+ and pH induced fusion of small unilamellar vesicles consisting of phosphatidylethanolamine and negatively charged phospholipids: a freeze fracture study. Biochem. Biophys. Res. Commun. 110:1983;15-22.
52. Tullius E.K., Williamson P., Schlegel R.A. Effect of transbilayer phospholipid distribution on erythrocyte fusion. Biosci. Rep. 9(5):1989;623-633.
53. Sessions A., Horwitz A.F. Differentiation-related differences in the plasma membrane phospholipid asymmetry of myogenic and fibrogenic cells. Biochim. Biophys. Acta. 728:1983;103-111.
54. Sessions A., Horwitz A.F. Differentiation-related differences in the plasma membrane phospholipid asymmetry of myogenic and fibrogenic cells. Biochim. Biophys. Acta. 728:1983;103-111.
55. Santini M.T., Indovina P.L., Cantafora A., Blotta I. The cesium-induced delay in myoblast membrane fusion is accompanied by changes in isolated membrane lipids. Biochim. Biophys. Acta. 1023:1990;298-304.
56. 2+-induced fusion of phospholipid vesicles containing free fatty acids: modulation by transmembrane pH gradients. Biochemistry. 31:1992;2629-2636.
57. Eastman S.J., Hope M.J., Wong K.F., Cullis P.R. Influence of phospholipid asymmetry on fusion between large unilamellar vesicles. Biochemistry. 31:1992;4262-4268.
58. Das S., Rand R.P. Modification by diacylglycerol of the structure and interaction of various phospholipid bilayer membranes. Biochemistry. 25:1986;2882-2889.
59. Sheetz M.P., Singer S.J. Biological membranes as bilayer couples. A molecular mechanism of drug-erythrocyte interactions. Proc. Natl. Acad. Sci. USA. 71:1974;4457-4461.
60. Sackmann E., Duwe H.-P., Engelhardt H. Membrane bending elasticity and its role for shape fluctuations and shape transformations of cells and vesicles. Faraday Discuss. Chem. Soc. 81:1986;281-290.
61. Berndl K., Kas J., Lipowsky R., Sackmann E., Seifert U. Europhys. Lett. 13:1990;659-664.
62. Farge E., Devaux P.F. Size-dependent response of liposomes to phospholipid transmembrane redistribution: from shape change to induced tension. J. Phys. Chem. 97:1993;2958-2961.
63. Kas J., Sackmann E. Shape transitions and shape stability of giant phospholipid vesicles in pure water induced by area-to-volume changes. Biophys. J. 60:1991;825-844.
64. Farge E., Devaux P.F. Shape changes of giant liposomes induced by an asymmetric transmembrane distribution of phospholipids. Biophys. J. 61:1992;347-357.
65. Mui B.L.S., Dobereiner H.-G., Madden T.D., Cullis P.R. Influence of transbilayer area asymmetry on the morphology of large unilamellar vesicles. Biophys. J. 69:1995;930-941.
66. 2+ in large unilamellar vesicles. Biochim. Biophys. Acta. 1025:1990;109-115.
67. Chakrabarti A.C., Viero J.A., Wong N.S., Wheeler J.J., Cullis P.R. Generation and characterization of iron and barium loaded liposomes. Biochim. Biophys. Acta. 1108:1992;233-239.
68. 2+ into large unilamellar vesicles in response to transmembrane pH gradients. Molecular Membrane Biology. 11:1994;151-158.
69. Kolber M.A., Haynes D.H. Fluorescence study of the divalent cation-transport mechanism of ionophore A23187 in phospholipid membranes. Biophys. J. 36:1981;369-391.
70. Hyono A., Hendriks T.H., Daemen F.J.M., Bonting S.L. Movement of calcium through artificial lipid membranes and the effects of ionophores. Biochim. Biophys. Acta. 389:1975;34-46.
71. 1H-NMR spectroscopy. Biosci. Rep. 2:1982;921-928.
72. Blau L., Stern R.B., Bittman R. The stoichiometry of A23187- and X537A-mediated calcium ion transport across lipid bilayers. Biochim. Biophys. Acta. 778:1984;219-223.
73. Runge V.M., Clanton J.A., Lukehart C.M., Partain C.L., James A.E. Am. Roentgen. Ray Soc. 141:1983;1209-1215.
74. Tilcock C., Ahkong Q.F., Koenig S.H., Brown R.D., Davis M., Kabalka G. The design of liposomal paramagnetic MR agents: effect of vesicle size upon the relaxivity of surface-incorporated lipophilic chelates. Magnet. Reson. Med. 27:1992;44-51.
75. Turner A.F., Presant C.A., Proffit R.T., Williams L.E., Windsor D.W., Werner J.L. In-111-labeled liposomes: dosimetry and tumor depiction. Radiology. 166:1988;761-765.
76. Rudnick G., Clark J. From synapse to vesicle: the reuptake and storage of biogenic amine neurotransmitters. Biochim. Biophys. Acta. 1144:1993;249-263.
77. Gu H., Wall S.C., Rudnick G. Stable expression of biogenic amine transporters reveals differences in inhibitor sensitivity, kinetics, and ion dependence. J. Biol. Chem. 269:1994;7124-7130.
78. Casey R.P., Njus D., Radda G.K., Sehr P.A. The biochemistry of the uptake, storage, and release of catecholamines. Biochemistry. 16:1977;972-977.
79. Njus D., Sehr P.A., Radda G.K., Ritchie G.A., Seeley P.J. Phosphorus-31 nuclear magnetic resonance studies of active proton translocation in chromaffin granules. Biochemistry. 17:1978;4337-4343.
80. Bally M.B., Mayer L.D., Loughrey H., Redelmeier T., Madden T.D., Wong K., Harrigan P.R., Cullis P.R. Dopamine accumulation in large unilamellar vesicle systems induced by transmembrane ion gradients. Chem. Phys. Lipids. 47:1988;97-107.
81. Berneis K.H., da Prada M., Pletscher A. Catecholamine transport through a lipid bilayer. Nature. 248:1974;604-606.
82. Knoth J., Isaacs J.M., Njus D. Amine transport in chromaffin granule ghosts. pH dependence implies cationic form is translocated. J. Biol. Chem. 256:1981;6541-6543.
83. Mack F., Bonisch H. Dissociation constants and lipophilicity of catecholamines and related compounds. Naunyn-Schmiedeberg's Arch. Pharmacol. 310:1979;1-9.
84. Sulzer D., Rayport S. Amphetamine and other psychostimulants reduce pH gradients in midbrain dopaminergic neurons and chromaffin granules: a mechanism of action. Neuron. 5:1990;797-808.
85. Moriyama Y., Tsai H.L., Futai M. Energy-dependent accumulation of neuron blockers causes selective inhibition of neurotransmitter uptake by brain synaptic vesicles. Arch. Biochem. Biophys. 305:1993;278-281.
86. Simon S., Roy D., Schindler M. Intracellular pH and the control of multidrug resistance. Proc. Natl. Acad. Sci. USA. 91:1994;1128-1132.
87. Endicott J.A., Ling V. The biochemistry of P-glycoprotein-mediated multidrug resistance. Annu. Rev. Biochem. 58:1989;137-171.
88. Dano K. Active outward transport of daunomycin in resistant Ehrlich ascites tumor cells. Biochim. Biophys. Acta. 323:1973;466-483.
89. Gottesman M.M., Pastan I. The multidrug transporter, a double-edged sword. J. Biol. Chem. 263:1988;12163-12166.
90. 3H]vinblastine from chinese hamster ovary cells transfected with a full-length complementary DNA clone for the mdr1 gene. Cancer Res. 49:1989;3867-3871.
91. Roepe P.D. Analysis of the steady-state and initial rate of doxorubicin efflux from a series of multidrug-resistant cells expressing different levels of P-glycoprotein. Biochemistry. 31:1992;12555-12564.
92. Higgins C.F., Gottesman M.M. Is the multidrug transporter a flippase? Trends Biochem. Sci. 17:1992;18-19.
93. Cornwell M.M., Safa A.R., Felsted R.L., Gottesman M.M., Pastan I. Membrane vesicles from multidrug-resistant human cancer cells contain a specific 150- to 170-kDa protein detected by photoaffinity labeling. Proc. Natl. Acad. Sci. USA. 83:1986;3847-3850.
94. Cornwell M.M., Tsuruo T., Gottesman M.M., Pastan I. ATP-binding properties of P-glycoprotein from multidrug-resistant KB cells. FASEB J. 1:1987;51-54.
95. Zamora J.M., Pearce H.L., Beck W.T. Physical-chemical properties shared by compounds that modulate multidrug resistance in human leukemic cells. Mol. Pharmacol. 33:1988;454-462.
96. W.T. Beck, in: I.B. Robinson (Ed.), Molecular and Cellular Biology of Multidrug Resistance in Tumour Cells, Plenum, New York, 1992, p. 215.
97. Thiebaut F., Currier S.J., Whitaker J., Hangland R.P., Gottesman M.M., Pastan I., Willingham M.C. Activity of the multidrug transporter results in alkalinization of the cytosol: measurement of cytosolic pH by microinjection of a pH-sensitive dye. J. Histochem. Cytochem. 38:1990;685-690.
98. Vaupel P., Kallinowski F., Okunieff P. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res. 49:1989;6449-6465.
99. i homeostasis in multidrug-resistant (MDR) cells: further characterization of a series of MDR cell lines expressing different levels of P-glycoprotein. Biochemistry. 32:1993;11042-11056.
100. N. Altan, S.M. Simon, M. Schindler, Role of subcellular pH in multidrug resistant human breast cancer cell lines, Biophysical Society Meeting, New Orleans, 1997.
101. Spoelstra E.C., Westerhoff H.V., Dekker H., Lankelma J. Kinetics of daunorubicin transport by P-glycoprotein of intact cancer cells. Eur. J. Biochem. 207:1992;567-579.
102. Rees-Jones R., Al-Awqati Q. Proton-translocating adenosinetriphosphatase in rough and smooth microsomes from rat liver. Biochemistry. 23:1984;2236-2240.
103. + uptake into a microsomal vesicle fraction from rat pancreatic acinar cells. J. Membr. Biol. 107:1989;263-275.
104. Trigatti B.L., Gerber G.E. The effect of intracellular pH on long-chain fatty acid uptake in 3T3-L1 adipocytes: evidence that uptake involves the passive diffusion of protonated long-chain fatty acids across the plasma membrane. Biochem. J. 313:1996;487-494.
105. Civelek et al., Intracellular pH in adipocytes: effects of free fatty acid diffusion across the plasma membrane, lipolytic agonists, and insulin. Proc. Natl. Acad. Sci. USA 93 (1996) 10139-10144.
106. Schaffer J.E., Lodish H.F. Expression cloning and characterization of a novel adipocyte long chain fatty acid transport protein. Cell. 79:1994;427-436.
107. Abumrad N.A., El-Maghrabi M.R., Amri E.-Z., Lopez E., Grimaldi P.A. Cloning of a rat adipocyte membrane protein implicated in binding or transport of long-chain fatty acids that is induced during preadipocyte differentiation. Homology with human CD36. J. Biol. Chem. 268:1993;17665-17668.
108. Op den Kamp J.A.F. Lipid asymmetry in membranes. Annu. Rev. Biochem. 48:1979;47-71.
109. Devaux P.F. Static and dynamic lipid asymmetry in cell membranes. Biochemistry. 30:1991;1163-1173.
110. Schroit A.J., Zwaal R.F.A. Transbilayer movement of phospholipids in red cell and platelet membranes. Biochim. Biophys. Acta. 1071:1991;313-329.
111. Gierasch L.M. Signal sequences. Biochemistry. 28:1989;923-930.
112. Rapoport T.A. Protein transport across the ER membrane. Trends Biochem. Sci. 15:1990;355-358.
113. Randall L.L. Function of protonmotive force in translocation of protein across membranes. Methods Enzymol. 125:1986;129-138.
114. Murem E.M., Randall L.L. Export of alpha-amylase by Bacillus amyloliquefaciens requires proton motive force. J. Bacteriol. 164:1985;712-716.
115. Bakker E.P., Randall L.L. The requirement for energy during export of beta-lactamase in Escherichia coli is fulfilled by the total protonmotive force. EMBO J. 3:1984;895-900.
116. Robinson C., Cai D., Hulford A., Brock I.W., Michl D., Hazell L., Schmidt I., Herrmann R.G., Klosgen R.B. The presequence of a chimeric construct dictates which of two mechanisms are utilized for translocation across the thylakoid membrane: evidence for the existence of two distinct translocation systems. EMBO J. 13:1994;279-285.
117. Chaddock A.M., Mant A., Karnauchov I., Brink S., Herrmann R.G., Klosgen R.B., Robinson C. A new type of signal peptide: central role of a twin-arginine motif in transfer signals for the delta pH-dependent thylakoidal protein translocase. EMBO J. 14:1995;2715-2722.
118. Brock I.W., Mills J.D., Robinson D., Robinson C. The delta pH-driven, ATP-independent protein translocation mechanism in the chloroplast thylakoid membrane. Kinet. Energet. J. Biol. Chem. 270:1995;1657-1662.
119. Mant A., Schmidt I., Herrmann R.G., Robinson C., Klosgen R.B. Sec-dependent thylakoid protein translocation. ΔpH requirement is dictated by passenger protein and ATP concentration. J. Biol. Chem. 270:1995;23275-23281.
120. R.A.F. Reithmeier, Assembly of proteins into membranes, in: D.E. Vance, J. Vance (Eds.), Biochemistry of Lipids, Lipoproteins, and Membranes (New Comprehensive Biochemistry Vol. 31), Elsevier Science B.V., Amsterdam, 1996, pp. 425-471.
121. Schatz G., Dobberstein B. Common principles of protein translocation across membranes. Science. 271:1996;1519-1526.
122. Rapoport T.A., Rolls M.M., Jungnickel B. Approaching the mechanism of protein transport across the ER membrane. Curr. Opin. Cell Biol. 8:1996;499-504.
123. Boman N.L., Bally M.B., Cullis P.R., Mayer L.D., Webb M.S. Encapsulation of vincristine in liposomes reduces its toxicity and improves its anti-tumour efficacy. J. Liposome Res. 5:1995;523-541.